In particular, high levels of BMI1, an oncogene highly expressed in acute myeloid leukemia and in advanced phases of CML, were connected to a poorer outcome, whereas on the other side a high expression of CBX6 and CBX7 played a favorable role (16). The gene discussed is BMI1; the disease is acute myeloid leukemia.